• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 437375 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414683937 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414683937 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Illumina Shares Climbing Higher, Up 1.4%

Published on Wed, 02/06/2013 - 11:26
By Robert Cotter

Up 1.4% to $51.70, Illumina (NASDAQ:ILMN), is one of today's notable movers. The S&P is currently trading fractionally lower to 1,509 and the Dow Jones Industrial Average is trading 0.2% lower to 13,945.

In the past 52 weeks, shares of Illumina have traded between a low of $25.57 and a high of $79.40 and are now at $51.70, which is 102% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has remained constant.

There is potential upside of 6.1% for shares of Illumina based on a current price of $51.70 and an average consensus analyst price target of $54.88. The stock should find resistance at its 50-day moving average (MA) of $52.52, as well as support at its 200-day MA of $46.39.

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

ePlus Shares Sinking Lower, Down 2.9%...

ePlus (NASDAQ:PLUS) is a company whose shares are active, trading 2.9% lower to $58.51. ...

Highest Future Earnings Growth in the To...

Below are the three companies in the Tobacco industry with the highest future earnings ...

Shares of Commercial Metals Under Pressu...

Commercial Metals (NYSE:CMC) is a company whose shares are active, trading 2.9% lower t ...

Top 3 Companies in the Life & Health Ins...

Below are the three companies in the Life & Health Insurance industry with the highest ...

Avago Technologies Makes a Move: Down 3....

Avago Technologies (NASDAQ:AVGO) is one of today's notable stocks in decline, down 3.0% ...

PEP Boys is Among the Companies in the A...

Below are the three companies in the Automotive Retail industry with the highest future ...

Nanometrics Shares Sinking Lower, Down 3...

Nanometrics (NASDAQ:NANO) is one of today's biggest movers, down 3.0% to $12.86. The S ...

Top 3 Companies in the Advertising Indus...

Below are the three companies in the Advertising industry with the highest future earni ...